Description:
Dr. Toresson brings extensive clinical experience with FMT and has published two major studies on its use in dogs with non-responsive or partially responsive chronic enteropathies. In this case-based seminar, she will explore the rationale behind FMT, review the latest research findings, and discuss how this therapy influences clinical and metabolic parameters in dogs with acute and chronic enteropathies. Current indications for FMT will be examined, and Dr Toresson will interpret real-world cases, connecting them to emerging evidence and best practices.
DATE:
Wednesday, January 14, 2026
2:00 pm-3:30 pm EST
Presenter:
Full Name
Linda Toresson DVM, Swedish Specialist in Small Animal Internal Medicine, PhD
Speaker Bio
Dr. Linda Toresson is a Swedish specialist in small animal internal medicine whose career integrates gastroenterology-focused clinical practice at Evidensia Specialist Animal Hospital with longstanding research. She earned her PhD in gastroenterology at Helsinki University in 2018, studying oral cobalamin supplementation in dogs with chronic enteropathies, and completed a 2024–2025 post-doctoral fellowship at the Texas A&M Gastrointestinal Laboratory focused on fecal microbiota transplantation and bile acid diarrhea. She has authored more than 20 scientific papers, contributed to multiple book chapters, and serves on several advisory boards, including the Companion Animal Fecal Bank Consortium and the Swedish Medical Product Agency’s Scientific Committee.
Location: Virtual Event
Click “Register Now” to save event link to your preferred calendar.